NASDAQ:AFIB Acutus Medical Q3 2023 Earnings Results & Report Acutus Medical beat analyst expectations on both earnings and revenue in its Q3 2023 results, released November 8, 2023. The company reported EPS of -$0.45 versus the -$0.57 consensus estimate, while revenue of $5.24 million topped the $5.10 million estimate by $0.14 million. Research:Profile Earnings Announcement Details QuarterQ3 2023Report DateNovember 8, 2023 Acutus Medical EPS ResultsActual EPS-$0.45Consensus EPS -$0.57Beat/MissBeat by +$0.12One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersAcutus Medical Revenue ResultsActual Revenue$5.24 millionExpected Revenue$5.10 millionBeat/MissBeat by +$140.00 thousandYoY Revenue GrowthN/AUpcoming EarningsAcutus Medical's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Acutus Medical Q3 2023 Earnings FAQ Did Acutus Medical beat earnings estimates for Q3 2023? Acutus Medical (NASDAQ:AFIB) reported earnings of -$0.45 per share for Q3 2023, beating the consensus estimate of -$0.57. The report was announced on Wednesday, November 8, 2023. What was Acutus Medical's revenue for Q3 2023? Acutus Medical reported revenue of $5.24 million for Q3 2023, against a consensus estimate of $5.10 million. When is Acutus Medical's next earnings date? Acutus Medical's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Acutus Medical on the company's earnings history page. Acutus Medical Earnings HeadlinesAFIB Acutus Medical, Inc. - Seeking AlphaJuly 1, 2025 | seekingalpha.comEnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology AssetsJuly 1, 2025 | finance.yahoo.comSpaceX is worth trillions. This one's $14.It is not SpaceX, Tesla, Starlink, or Neuralink. But Elon's rocket company shows up in this stock's paperwork, and anyone with a brokerage account can buy shares for about 14 dollars. When SpaceX went public, roughly 4,400 employees became what Dylan Jovine calls the first wave of Space Millionaires. He believes a second wave begins December 8th, when the lockup ends. | Behind the Markets (Ad)Acutus Medical Stock Short Interest Report | OTC:AFIB | BenzingaMay 26, 2025 | benzinga.comAcutus Medical Reports Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comSee More Acutus Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email. Email Address About Acutus MedicalAcutus Medical (NASDAQ:AFIB) was a medical device company focused on improving the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company developed technologies intended to help electrophysiologists create detailed three-dimensional maps of the heart and guide catheter-based ablation procedures. Its principal product was the AcQMap electrophysiology imaging and mapping system, which combined ultrasound-based imaging with electrical mapping to visualize cardiac anatomy and arrhythmia activity. The system was designed to support the identification of abnormal electrical signals and assist physicians in planning and performing ablation treatments. Acutus also developed associated mapping catheters, software and related procedural tools. Founded in 2011 and headquartered in Carlsbad, California, Acutus marketed its products in the United States and select international markets, including Europe. The company completed its initial public offering on the Nasdaq under the symbol AFIB in 2020. In 2023, Acutus announced an agreement to sell substantially all of its assets to Medtronic, after which its standalone operations were wound down.View Acutus Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles SpaceX Earnings Launch: High Margins Fund AI AmbitionsGM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?Synchrony Aces The Quarter As Credit Fears FadeHigher Rates Are Sending Investors to These 3 Dividend KingsServiceNow Orchestrates AI's Next Act—Can Earnings Deliver?Swiping to Record Highs: Why Visa Remains a FortressDrone Stocks Have Burned Investors—Are These 4 Different? Upcoming Earnings ENI (10/23/2026)SLB (10/23/2026)American Express (10/23/2026)Infosys (10/23/2026)Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
